Alginate-based microcapsules for immunoisolation of pancreatic islets

Biomaterials

Volumn 27, Issue 32, 2006, Pages 5603-5617

  de Vos, Paul ^a   Faas, Marijke M ^a   Strand, Berit ^b   Calafiore, Ricardo ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Alginate; Immunoisolation; Islets; Macroencapsulation; Microencapsulation; Vascularization

Indexed keywords

CAPSULES; IMMUNOISOLATED CELLS; IMMUNOSUPPRESSION; PANCREATIC ISLETS;

BIOCOMPATIBILITY; BIOLOGICAL MEMBRANES; CELLS; DISEASES; IMMUNOLOGY; TISSUE;

BIOMATERIALS;

ALGINIC ACID; CYTOKINE; GLUCOSE;

ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; CELL ENCAPSULATION; CELL ISOLATION; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; COATED PARTICLE; CROSS LINKING; CYTOKINE PRODUCTION; DEPOLYMERIZATION; FOURIER ANALYSIS; GELATION; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MATERIAL COATING; MICROENCAPSULATION; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; VISCOSITY; X RAY SPECTROMETRY;

ALGINATES; ANIMALS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; MICROSCOPY, ATOMIC FORCE;

ANIMALIA;

EID: 33746782944     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.07.010     Document Type: Review

References (144)

1. Lim F., and Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210 (1980) 908-910
2. Soon-Shiong P., Feldman E., Nelson R., Heintz R., Merideth N., Sandford P., et al. Long-term reversal of diabetes in the large animal model by encapsulated islet transplantation. Transplant Proc 24 6 (1992) 2946-2947
3. De Vos P., De Haan B.J., Wolters G.H.J., Strubbe J.H., and Van Schilfgaarde R. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 40 (1997) 262-270
4. Omer A., Duvivier-Kali V.F., Trivedi N., Wilmot K., Bonner-Weir S., and Weir G.C. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 52 (2003) 69-75
5. Zimmermann H., Zimmermann D., Reuss R., Feilen P.J., Manz B., Katsen A., et al. Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation. J Mater Sci Mater Med 16 (2005) 491-501
6. Koo J., and Chang T.S.M. Secretion of erythropoietin from microencapsulated rat kidney cells. Int J Artif Organs 16 (1993) 557-560
7. Chang P.L., Shen N., and Westcott A.J. Delivery of recombinant gene products with microencapsulated cells in vivo. Hum Gene Ther 4 (1993) 433-440
8. Liu H.W., Ofosu F.A., and Chang P.L. Expression of human factor IX by microencapsulated recombinant fibroblasts. Hum Gene Ther 4 (1993) 291-301
9. Cieslinski D.A., and Humes H.D. Tissue engineering of a bioartificial kidney. Biotechnol Bioeng 43 (1994) 678-681
10. Wong H., and Chang T.M. Bioartificial liver: implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int J Artif Organs 9 (1986) 335-336
11. Aebischer P., Russell P.C., Christenson L., Panol G., Monchik J.M., and Galletti P.M. A bioartificial parathyroid. ASAIO Trans 32 (1986) 134-137
12. Aebischer P., Goddard M., Signore A.P., and Timpson R.L. Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Exp Neurol 126 (1994) 151-158
13. Hasse C., Klöck G., Schlosser A., Zimmermann U., and Rothmund M. Parathyroid allotransplantation without immunosuppression. Lancet 350 (1997) 1296-1297
14. Soon Shiong P., Heintz R.E., Merideth N., Yao Q.X., Yao Z., Zheng T., et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343 (1994) 950-951
15. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Calabrese G., et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetic Care 29 (2006) 137-138
16. Williams DF. Summary and definitions. Progress in biomedical engineering: definition in biomaterials (4). Amsterdam: Elsevier Science Publisher BV; 1987. p. 66-71.
17. De Vos P., and Van Schilfgaarde R. Biocompatibility issues. In: Kühtreiber W.M., Lanza R.P., and Chick W.L. (Eds). Cell encapsulation technology and therapeutics (1999), Birkhäuser, Boston 63-79
18. De Vos P., and Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45 (2002) 159-173
19. Zielinski B.A., and Aebischer P. Chitosan as a matrix for mammalian cell encapsulation. Biomaterials 15 (1994) 1049-1056
20. Iwata H., Amemiya H., Matsuda T., Takano H., Hayashi R., and Akutsu T. Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation. Diabetes 38 Suppl. 1 (1989) 224-225
21. Dawson R.M., Broughton R.L., Stevenson W.T., and Sefton M.V. Microencapsulation of CHO cells in a hydroxyethyl methacrylate-methyl methacrylate copolymer. Biomaterials 8 (1987) 360-366
22. Kessler L., Pinget M., Aprahamian M., Dejardin P., and Damge C. In vitro and in vivo studies of the properties of an artificial membrane for pancreatic islet encapsulation. Horm Metab Res 23 (1991) 312-317
23. Cruise G.M., Hegre O.D., Lamberti F.V., Hager S.R., Hill R., Scharp D.S., et al. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant 8 (1999) 293-306
24. Fritschy W.M., Wolters G.H., and Van Schilfgaarde R. Effect of alginate-polylysine-alginate microencapsulation on in vitro insulin release from rat pancreatic islets. Diabetes 40 (1991) 37-43
25. King A, Sandler S, Andersson A, Hellerstrom C, Kulseng B, Skjak-Braek G. Glucose metabolism in vitro of cultured and transplanted mouse pancreatic islets microencapsulated by means of a high-voltage electrostatic field. Diabetes Care 1999;22 Suppl. 2B121-6 *LHM.
26. De Haan B.J., Faas M.M., and De Vos P. Factors influencing insulin secretion from encapsulated islets. Cell Transplant 12 (2003) 617-625
27. Sandler S., Andersson A., Eizirik D.L., Hellerstrom C., Espevik T., Kulseng B., et al. Assessment of insulin secretion in vitro from microencapsulated fetal porcine islet-like cell clusters and rat, mouse, and human pancreatic islets. Transplantation 63 (1997) 1712-1718
28. Lopez-Avalos M.D., Tatarkiewicz K., Sharma A., Bonner-Weir S., and Weir G.C. Enhanced maturation of porcine neonatal pancreatic cell clusters with growth factors fails to improve transplantation outcome. Transplantation 71 (2001) 1154-1162
29. Donati I., Holtan S., Morch Y.A., Borgogna M., Dentini M., and Skjak-Braek G. New hypothesis on the role of alternating sequences in calcium-alginate gels. Biomacromolecules 6 (2005) 1031-1040
30. Smidsrod O. Molecular basis for some physical properties of alginates in the gel state. J Chem Soc Faraday Trans 57 (1974) 263-274
31. De Vos P., Andersson A., Tam S.K., Faas M.M., and Halle J.P. Advances and barriers in mammalian cell encapsulation for treatment of diabetes. Immun Endoc Metab Agents Med Chem 139-153 (2006)
32. Thu B., Bruheim P., Espevik T., Smidrod O., Soon-Shiong P., and Skjak-Braek G. Alginate polycation microcapsules. I. Interaction between alginate and polycation. Biomaterials 17 (1996) 1031-1040
33. Morch YA, Donati I, Strand BL, Skjåk-Bræk G. Effect of Ca, Ba and Sr on alginate microbeads. Biomacromolecules 2006.
34. Smidsrod O., and Skjak-Break G. Alginate as immobilization matrix for cells. Trends Biotechnol 8 (1990) 71-78
35. Martinsen A., Skjåk-Bræk G., and Smidsrod O. Alginate as Immobilization material: I correlation between chemical and physical properties of alginate beads. Biotech Bioeng 33 (1989) 79-83
36. Thu B., Bruheim P., Espevik T., Smidrod O., Soon-Shiong P., and Skjak-Break G. Alginate polycation microcapsules II. Some functional properties. Biomaterials 17 (1996) 1069-1079
37. Flo T.H., Ryan L., Latz E., Takeuchi O., Monks B.G., Lien E., et al. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J Biol Chem 277 (2002) 35489-35495
38. Kulseng B., Skjak-Braek G., Ryan L., Andersson A., King A., Faxvaag A., et al. Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. Transplantation 67 (1999) 978-984
39. Stokke B.T., Smidrod O., Bruheim P., and Skjåk-Bræk G. Distribution of uronate residues in alginate chains in relation to alginate gelling properties. Macromolecules 24 (1991) 4637
40. Skjak-Break G. Alginate as immobilization material II: determination of polyphenol contaminants by fluorescence spectroscopy, and evaluation of methods for their removal. Biotechnol Bioeng 33 (1989) 90-94
41. Haug A., and Larsen B. The solibility of alginate at low pH. Acta Chem Scand 17 (1963) 1653-1662
42. Klöck G., Frank H., Houben R., Zekorn T., Horcher A., Siebers U., et al. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 40 (1994) 638-643
43. Zimmermann U., Thurmer F., Jork A., Weber M., Mimietz S., Hillgartner M., et al. A novel class of amitogenic alginate microcapsules for long-term immunoisolated transplantation. Ann N Y Acad Sci. 944 (2001) 199-215
44. Dusseault J., Tam S.K., Menard M., Polizu S., Jourdan G., Yahia L., et al. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. J Biomed Mater Res A 76 (2006) 243-251
45. De Vos P., De Haan B., and Van Schilfgaarde R. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 18 (1997) 273-278
46. Elliott R.B., Escobar L., Calafiore R., Basta G., Garkavenko O., Vasconcellos A., et al. Transplantation of micro- and macroencapsulated piglet islets into mice and monkeys. Transplant Proc 37 (2005) 466-469
47. De Vos P., Van Hoogmoed C.G., and Busscher H.J. Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells. J Biomed Mater Res 60 (2002) 252-259
48. De Vos P., Van Hoogmoed C.G., van Zanten J., Netter S., Strubbe J.H., and Busscher H.J. Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets. Biomaterials 24 (2003) 305-312
49. Hasse C., Zielke A., Klock G., Schlosser A., Barth P., Zimmermann U., et al. Amitogenic alginates: key to first clinical application of microencapsulation technology. World J Surg 22 (1998) 659-665
50. Hasse C., Klock G., Zielke A., Schlosser A., Barth P., Zimmermann U., et al. Transplantation of parathyroid tissue in experimental hypoparathyroidism: in vitro and in vivo function of parathyroid tissue microencapsulated with a novel amitogenic alginate. Int J Artif Organs 19 (1996) 735-741
51. Klöck G., Frank H., Houben R., Zekorn T., Horcher A., Siebers U., et al. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 40 (1994) 638-643
52. Klöck G., Pfeffermann A., Ryser C., Gröhn P., Kuttler B., Hahn H.J., et al. Biocompatibility of mannuronic acid-rich alginates. Biomaterials 18 (1997) 707-713
53. Zekorn T., KlÖck G., Horcher A., Siebers U., WÖhrle M., Kowalski M., et al. Lymphoid activation by different crude alginates and the effect of purification. Transplant Proc 24 (1992) 2952-2953
54. Duvivier-Kali V.F., Omer A., Parent R.J., O'Neil J.J., and Weir G.C. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50 (2001) 1698-1705
55. Robitaille R., Dusseault J., Henley N., Desbiens K., Labrecque N., and Halle J.P. Inflammatory response to peritoneal implantation of alginate-poly-l-lysine microcapsules. Biomaterials 26 (2005) 4119-4127
56. Tam S.K., Dusseault J., Polizu S., Menard M., Halle J.P., and Yahia L. Impact of residual contamination on the biofunctional properties of purified alginates used for cell encapsulation. Biomaterials 27 (2006) 1296-1305
57. Orive G., Tam S.K., Pedraz J.L., and Halle J.P. Biocompatibility of alginate-poly-l-lysine microcapsules for cell therapy. Biomaterials 27 (2006) 3691-3700
58. De Vos P., van Straaten J.F., Nieuwenhuizen A.G., de Groot M., Ploeg R.J., De Haan B.J., et al. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?. Diabetes 48 (1999) 1381-1388
59. Geisen K., Deutschländer H., Gorbach S., et al. Function of barium alginate-microencapsulated xenogenic islets in different diabetic mouse models. In: Shafrir E. (Ed). Frontiers in diabetes research. Lessons from animal diabetes III (1990), Smith-Gordon 142-148
60. 2+-alginate microcarriers for the culture of anchorage-dependent mammalian cells. BioTechniques 22 (1997) 970-972
61. 2+-alginate-coated islets of Langerhans for immunoisolation. Exp Clin Endocrinol 102 (1994) 380-387
62. Siebers U., Zekorn T., Horcher A., Hering B., Bretzel R.G., Zimmermann U., et al. In vitro testing of rat and porcine islets microencapsulated in barium alginate beads. Transplant Proc 24 (1992) 950-951
63. Zekorn T., Siebers U., Horcher A., Schnettler R., Klock G., Bretzel R.G., et al. Barium-alginate beads for immunoisolated transplantation of islets of Langerhans. Transplant Proc 24 (1992) 937-939
64. Omer A., Duvivier-Kali V., Fernandes J., Tchipashvili V., Colton C.K., and Weir G.C. Long-term normoglycemia in rats receiving transplants with encapsulated islets. Transplantation 79 (2005) 52-58
65. Finegood D.T., Scaglia L., and Bonner-Weir S. Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 44 (1995) 249-256
66. Omer A., Keegan M., Czismadia E., De Vos P., Van Rooijen N., Bonner-Weir S., et al. Macrophage depletion improves survival of porcine neonatal pancreatic cell clusters contained in alginate macrocapsules transplanted into rats. Xenotransplantation 10 (2003) 240-251
67. Bystricky S., Malovikova A., and Sticzay T. Interaction of acid polysaccharides with polylysine enantiomers, conformation probe in solution. Carbohydr Polym 15 (1991) 299-308
68. Bystricky S., Malovikova A., and Sticzay T. Interaction of alginate and pectins with cationic polypeptides. Carbohydr Res 13 (1990) 283-294
69. Vandenbossche G.M., Bracke M.E., Cuvelier C.A., Bortier H.E., Mareel M.M., and Remon J.P. Host reaction against empty alginate-polylysine microcapsules. Influence of preparation procedure. J Pharm Pharmacol 45 (1993) 115-120
70. King G.A., Daugulis A.J., Faulkner P., and Goosen M.F.A. Alginate-polylysine microcapsules of controlled membrane molecular weight cutoff for mammalian cell culture engineering. Biotechnol Prog 3 (1987) 231-240
71. Halle J.P., Leblond F.A., Landry D., Fournier A., and Chevalier S. Studies of 300-μm microcapsules: I. use of arginine esterase release by microencapsulated prostatic cells as a measure of membrane permeability. Transplant Proc 24 (1992) 2930-2932
72. Kulseng B., Thu B., Espevik T., and Skjak Braek G. Alginate polylysine microcapsules as immune barrier: permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplant 6 (1997) 387-394
73. Clayton H.A., London N.J.M., Colloby P.S., Bell P.R.F., and James R.F.L. The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules. J Microencapsul 8 (1991) 221-233
74. Vandenbossche GMR, Bracke ME, Cuvelier CA, Bortier HE, Mareel AA, Remon JP. Host reaction against empty alginate-polylysine microcapsules. (i) Influence of preparation procedure. Onbekend 1994.
75. Strand B.K., Ryan L., In 't Veld P., Kulseng B., Rokstad A.M., Skjåk-Braek G., et al. Poly-l-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant 10 (2001) 263-277
76. King A., Sandler S., and Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res 57 (2001) 374-383
77. Van Hoogmoed C.G., Busscher H.J., and De Vos P. Fourier transform infrared spectroscopy studies of alginate-PLL capsules with varying compositions. J Biomed Mater Res 67A (2003) 172-178
78. De Vos P., Van Hoogmoed C.G., De Haan B.J., and Busscher H.J. Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period. J Biomed Mater Res 62 (2002) 430-437
79. Dupuy B., Arien A., and Perrot Minnot A. FI-IR of membranes made with alginate-polylysine complexes. Variations with mannuronic or guluronic content of the polysaccharides. Artif Cells Blood Subs Immob Biotech 22 (1994) 71-82
80. Strand B.L., Morch Y.A., Espevik T., and Skjak-Braek G. Visualization of alginate-poly-l-lysine-alginate microcapsules by confocal laser scanning microscopy. Biotechnol Bioeng 82 (2003) 386-394
81. Tam K.T., Dusseault J., Polizu S., Ménard M., Hallé J.P., and L'Hocine Y. Physicochemical model of alginate-poly-l-lysine microcapsules defined at the micrometric/nanometric scale using ATR-FTIR, XPS, and ToF-SIMS. Biomaterials (2005) 6950-6961
82. De Vos P., Wolters G.H.J., and Van Schilfgaarde R. Possible relationship between fibrotic overgrowth of alginate-polylysine-alginate microencapsulated pancreatic islets and the microcapsule integrity. Transplant Proc 26 (1994) 782-783
83. De Vos P., De Haan B.J., Pater J., and Van Schilfgaarde R. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. Transplantation 62 (1996) 893-899
84. Strand B.L., Morch Y.A., Espevik T., and Skjak-Braek G. Visualization of alginate-poly-l-lysine-alginate microcapsules by confocal laser scanning microscopy. Biotechnol Bioeng 82 (2003) 386-394
85. King A., Strand B., Rokstad A.M., Kulseng B., Andersson A., Skjak-Braek G., et al. Improvement of the biocompatibility of alginate/poly-l-lysine/alginate microcapsules by the use of epimerized alginate as a coating. J Biomed Mater Res 64A (2003) 533-539
86. De Vos P, De Haan BJ, Faas MM, Kitano T. Zeta-potentials of alginate-PLL capsules; a predictive measure for biocompatibility? J Biomed Mater Res 2006.
87. Kitano T., Ateshian G.A., Mow V.C., Kadoya Y., and Yamano Y. Constituents and pH changes in protein rich hyaluronan solution affect the biotribological properties of artificial articular joints. J Biomech 34 (2001) 1031-1037
88. Kitano T., Ohashi H., Kadoya Y., Kobayashi A., Yutani Y., and Yamano Y. Measurements of zeta potentials of particulate biomaterials in protein-rich hyaluronan solution with changes in pH and protein constituents. J Biomed Mater Res 42 (1998) 453-457
89. Kitano T., Yutani Y., Shimazu A., Yano I., Ohashi H., and Yamano Y. The role of physicochemical properties of biomaterials and bacterial cell adhesion in vitro. Int J Artif Organs 19 (1996) 353-358
90. Bunger C.M., Gerlach C., Freier T., Schmitz K.P., Pilz M., Werner C., et al. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules. J Biomed Mater Res 67A (2003) 1219-1227
91. Kizilel S., Garfinkel M., and Opara E. The bioartificial pancreas: progress and challenges. Diabetes Technol Ther 7 (2005) 968-985
92. Calafiore R., Basta G., Luca G., Calvitti M., Calabrese G., Racanicchi L., et al. Grafts of microencapsulated pancreatic islet cells for the therapy of diabetes mellitus in non-immunosuppressed animals. Biotechnol Appl Biochem 39 (2004) 159-164
93. Luca G., Nastruzzi C., Calvitti M., Becchetti E., Baroni T., Neri L.M., et al. Accelerated functional maturation of isolated neonatal porcine cell clusters: in vitro and in vivo results in NOD mice. Cell Transplant 14 (2005) 249-261
94. De Vos P., Hillebrands J.L., De Haan B.J., Strubbe J.H., and Van Schilfgaarde R. Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. Transplantation 63 (1997) 824-830
95. De Vos P., and Marchetti P. Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. Trends Mol Med 8 (2002) 363-366
96. Petruzzo P., Pibiri L., De Giudici M.A., Basta G., Calafiore R., Falorni A., et al. Xenotransplantation of microencapsulated pancreatic islets contained in a vascular prosthesis: preliminary results. Transpl Int 4 (1991) 200-204
97. Mueller-Klieser W., Freyer J.P., and Sutherland R.M. Influence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroids. Br J Cancer 53 (1986) 345-353
98. Mueller-Klieser W.F., and Sutherland R.M. Influence of convection in the growth medium on oxygen tensions in multicellular tumor spheroids. Cancer Res 42 (1982) 237-242
99. Dionne K.E., Colton C.K., and Yarmush M.L. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 42 (1993) 12-21
100. Dionne K.E., Colton C.K., and Yarmush M.L. Effect of oxygen on isolated pancreatic tissue. ASAIO Trans 35 (1989) 739-741
101. Schrezenmeir J., Gero L., Laue C., Kirchgessner J., Muller A., Huls A., et al. The role of oxygen supply in islet transplantation. Transplant Proc 24 (1992) 2925-2929
102. Schrezenmeir J., Kirchgessner J., Gero L., Kunz L.A., Beyer J., and Mueller-Klieser W. Effect of microencapsulation on oxygen distribution in islets organs. Transplantation 57 (1994) 1308-1314
103. Hommel M, Sun AM, Goosen MFA. Canada patent 458605. 1984 (GENERIC) Ref type: Patent.
104. Lum Z.P., Krestow M., Tai I.T., Vacek I., and Sun A.M. Xenografts of rat islets into diabetic mice. Transplantation 53 6 (1992) 1180-1183
105. Halle J.P., Leblond F.A., Pariseau J.F., Jutras P., Brabant M.J., and Lepage Y. Studies on small (<300 μm) microcapsules: II-parameters governing the production of alginate beads by high voltage electrostatic pulses. Cell Transplant 3 (1994) 365-372
106. De Vos P., De Haan B.J., Wolters G.H.J., and Van Schilfgaarde R. Factors influencing the adequacy of microencapsulation of rat pancreatic islets. Transplantation 62 (1996) 888-893
107. De Vos P., De Haan B.J., and Van Schilfgaarde R. Upscaling the production of encapsulated islets. Biomaterials 18 (1997) 1085-1090
108. Desai T.A. Microfabrication technology for pancreatic cell encapsulation. Expert Opin Biol Ther 2 (2002) 633-646
109. Uludag H., de-Vos P., and Tresco P.A. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev 42 (2000) 29-64
110. Duvivier-Kali V.F., Omer A., Parent R.J., O'Neil J.J., and Weir G.C. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50 (2001) 1698-1705
111. King A., Sandler S., and Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res 57 (2001) 374-383
112. King A., Andersson A., Strand B.L., Lau J., Skjak-Braek G., and Sandler S. The role of capsule composition and biologic responses in the function of transplanted microencapsulated islets of Langerhans. Transplantation 76 (2003) 275-279
113. Cardozo A.K., Proost P., Gysemans C., Chen M.C., Mathieu C., and Eizirik D.L. IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46 (2003) 255-266
114. de-Groot M., Keizer P.P.M., de-Haan B.J., Schuurs T.A., Leuvenink H.G.D., van-Schilfgaarde R., et al. Microcapsules and their ability to protect islets against cytokine mediated dysfunction. Transplant Proc 33 (2001) 1711-1712
115. De Vos P, Smedema I, van Goor H, Moes H, van Zanten J, de Leij LFM, et al. Association between macrophages activation and function of microencapsulated islets. Diabetologia 2003.
116. De Vos P., De Haan B.J., van Zanten J., and Faas M.M. Factors influencing functional survival of microencapsulated islets. Cell Transplant 13 (2004) 515-524
117. De Vos P., De Haan B.J., Vegter D., Hillebrands J.L., Strubbe J.H., Bruggink J.E., et al. Insulin levels after portal and systemic insulin infusion differ in a dose-dependent fashion. Horm Metab Res 30 (1998) 721-725
118. Tang L., and Eaton J.W. Inflammatory responses to biomaterials. Am J Clin Pathol 103 (1995) 466-471
119. Rihova B. Immunocompatibility and biocompatibility of cell delivery systems. Adv Drug Deliv Rev 42 (2000) 65-80
120. Tang L., and Eaton J.W. Natural responses to unnatural materials: a molecular mechanism for foreign body reactions. Mol Med 5 (1999) 351-358
121. Tang L., Jennings T.A., and Eaton J.W. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci USA 95 (1998) 8841-8846
122. Babensee J.E., Anderson J.M., McIntire L.V., and Mikos A.G. Host response to tissue engineered devices. Adv Drug Deliv Rev 33 (1998) 111-139
123. Hunt J.A., McLaughlin P.J., and Flanagan B.F. Techniques to investigate cellular and molecular interactions in the host response to implanted biomaterials. Biomaterials 18 (1997) 1449-1459
124. Lanza R.P., and Chick W.L. Immunoisolation: at a turning point. Immunol Today 18 (1997) 135-139
125. Lanza R.P., Ecker D.M., Kühtreiber W.M., Marsh J.P., and Chick W.L. Simple and inexpensive method for transplanting xenogeneic cells and tissues into rats using alginate gel spheres. Transplant Proc 27 (1995) 3322
126. Lanza R.P., Beyer A.M., and Chick W.L. Xenogeneic humoral responses to islets transplanted in biohybrid diffusion chambers. Transplantation 57 (1994) 1371-1375
127. Dufrane D., Steenberghe M., Goebbels R.M., Saliez A., Guiot Y., and Gianello P. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 27 (2006) 3201-3208
128. Bolzan A.D., and Bianchi M.S. Genotoxicity of streptozotocin. Mutat Res 512 (2002) 121-134
129. de Groot M., Keizer P.P., De Haan B.J., Schuurs T.A., Leuvenink H.G., Van Schilfgaarde R., et al. Microcapsules and their ability to protect islets against cytokine-mediated dysfunction. Transplant Proc 33 (2001) 1711-1712
130. King A., Andersson A., and Sandler S. Cytokine-induced functional suppression of microencapsulated rat pancreatic islets in vitro. Transplantation 70 (2000) 380-383
131. Basta G., Sarchielli P., Luca G., Racanicchi L., Nastruzzi C., Guido L., et al. Optimized parameters for microencapsulation of pancreatic islet cells: an in vitro study clueing on islet graft immunoprotection in type 1 diabetes mellitus. Transpl Immunol 13 (2004) 289-296
132. Piro S., Lupi R., Dotta F., Patane G., Rabuazzo M.A., Marselli L., et al. Bovine islets are less susceptible than human islets to damage by human cytokines. Transplantation 71 (2001) 21-26
133. Trivedi N., Steil G.M., Colton C.K., Bonner-Weir S., and Weir G.C. Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant 9 (2000) 115-124
134. Yoon K.H., Quickel R.R., Tatarkiewicz K., Ulrich T.R., Hollister-Lock J., Trivedi N., et al. Differentiation and expansion of beta cell mass in porcine neonatal pancreatic cell clusters transplanted into nude mice. Cell Transplant 8 (1999) 673-689
135. Cruise G.M., Hegre O.D., Scharp D.S., and Hubbell J.A. A sensitivity study of the key parameters in the interfacial photopolymerization of poly(ethylene glycol) diacrylate upon porcine islets. Biotechnol Bioeng 57 (1998) 655-665
136. Cruise G.M., Hegre O.D., Lamberti F.V., Hager S.R., Hill R., Scharp D.S., et al. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant 8 (1999) 293-306
137. Bonnet C.S., and Walsh D.A. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 44 (2005) 7-16
138. Auguste P., Lemiere S., Larrieu-Lahargue F., and Bikfalvi A. Molecular mechanisms of tumor vascularization. Crit Rev Oncol Hematol 54 (2005) 53-61
139. De Vos P., Vegter D., De Haan B.J., Strubbe J.H., Bruggink J.E., and Van Schilfgaarde R. Kinetics of intraperitoneally infused insulin in rats: functional implications for the bioartificial pancreas. Diabetes 45 (1996) 1102-1107
140. De Vos P., Vegter D., Strubbe J.H., De Haan B.J., and Van Schilfgaarde R. Impaired glucose tolerance in recipients of an intraperitoneally implanted microencapsulated islet allograft is caused by the slow diffusion of insulin through the peritoneal membrane. Transplant Proc 29 (1997) 756-757
141. Tatarkiewicz K., Garcia M., Omer A., Van Schilfgaarde R., Weir G.C., and De Vos P. C-peptide responses after meal challenge in mice transplanted with microencapsulated rat islets. Diabetologia 44 (2001) 646-653
142. Soon-Shiong P., Otterlei M., Skjåk-Bræk G., Smidsrod O., Heintz R., Lanza R.P., et al. An immunological basis for the fibrotic reaction to implanted microcapsules. Transplant Proc 23 (1991) 758-759
143. Zimmermann U., KlÖck G., Federlin K., Hannig K., Kowalski M., Bretzel R.G., et al. Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis 13 (1992) 269-274
144. De Vos P., Wolters G.H., Fritschy W.M., and Van Schilfgaarde R. Obstacles in the application of microencapsulation in islet transplantation. Int J Artif Organs 16 (1993) 205-212